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Abstract
Background: Little is known about the effect of migrant status on childhood cancer survival. We
studied cancer survival among children of Turkish descent in the German Cancer Childhood
Registry, one of the largest childhood cancer registries worldwide.
Methods: We identified children of Turkish descent among cancer cases using a name-based
approach. We compared 5-year survival probabilities of Turkish and other children in three time
periods of diagnosis (1980–87, 1988–95, 1996–2005) using the Kaplan-Meier method and log-rank
tests.
Results: The 5-year survival probability for all cancers among 1774 cases of Turkish descent
(4.76% of all 37.259 cases) was 76.9% compared to 77.6% in the comparison group (all other cases;
p = 0.15). We found no age- or sex-specific survival differences (p-values between p = 0.18 and p
= 0.90). For the period 1980–87, the 5-year survival probability among Turkish children with
lymphoid leukaemia was significantly lower (62% versus 75.8%; p < 0.0001), this remains
unexplained. For more recently diagnosed leukaemias, we saw no survival differences for Turkish
and non-Turkish children.
Conclusion: Our results suggest that nowadays Turkish migrant status has no bearing on the
outcome of childhood cancer therapies in Germany. The inclusion of currently more than 95% of
all childhood cancer cases in standardised treatment protocols is likely to contribute to this finding.
Background
Mortality from childhood cancer has been declining for
almost all cancers in most industrialised countries. 5 year-
survival probabilities have been improving between 30%
and 50% for childhood cancers evaluated by European
registries when comparing the period 1978–1982 to the
period 1993–1997 [1]; survival probabilities have
improved further in more recent years (see for example
data from http://www.kinderkrebsregister.de). This is due
to increasingly effective and highly standardised therapeu-
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tic regimes. Country specific analyses in the Automated
Childhood Cancer Information System (ACCIS) database
show marked survival probability variations especially
between childhood cancer in Eastern and Western-Euro-
pean populations (overall survival 1988–97 East: 62%,
West: 75%) [1,2], indicating an influence of socioeco-
nomic conditions at the national level.
Socioeconomic status has long been known to influence
cancer survival [3]. Migrants and their families may be
particularly affected by these effects because of difficulties
to obtain and maintain appropriate access to care [4].
However, little is known about childhood cancer inci-
dence and survival among migrants. Hemminki & Li [5]
found increased cancer risks for migrant children of differ-
ent origins and for different diagnoses compared to Swed-
ish children. Data from Great Britain indicate that in
1991–92 children with South Asian ethnic background
had an increased cancer incidence when compared to non
South Asians [6]. For Germany no incidence comparisons
exist, but evaluations of proportional cancer incidence
ratios [7] showed little variation between children of
Turkish descent as compared to other children.
Few data exist on survival probabilities of migrants. Over-
all survival seems not to differ between ethnic groups in
Great Britain [8,9], with a possible exception of acute lym-
phoid leukaemia with lower survival probability among
UK children of South Asian ethnic background. In the US,
there is conflicting evidence concerning ethnic differences
in survival probability after childhood acute lymphoid
leukaemia [10-12]. For acute myeloid leukaemia the sur-
vival probability of US black and Hispanic children is
lower than for white children [13].
Apart from ethnic German immigrants from the former
USSR, Turkish people are the largest migrant group in Ger-
many, comprising about 1.7 million people in 2007
according to nationality [14], and about 2.4 million when
all persons with Turkish migration history are taken into
account, including naturalised immigrants and their chil-
dren [15]. We aimed to study whether a migration back-
ground affects survival from childhood cancer in
Germany. Therefore, we undertook a registry-based analy-
sis of cancer survival of children with Turkish descent in
Germany, using data from the German Childhood Cancer
Registry (GCCR) for the period 1980–2005.
Methods
The GCCR is one of the largest cancer registries worldwide
dedicated to children. Annually, about 1800 new cases
under 15 years of age are recorded, and the completeness
of registration exceeds 95% for all cancer types except cen-
tral nervous system (CNS) tumours, where completeness
is somewhat lower as expected by inter-registry compari-
sons. No information on ethnicity, and consequently on
completeness by ethnicity is available. The GCCR started
registering cases in 1980. The current degree of complete-
ness was reached around 1987. Registration with full
identification is possible with parental consent, and
almost all cases are registered with names. In addition,
parents' names are available for about 50% of all cases. A
vital status follow-up is conducted routinely using infor-
mation from various sources (clinical studies, hospitals,
communities, families). Close cooperation exists between
paediatric oncologists and the registry. As almost all chil-
dren with cancer in Germany enter into clinical trials, this
cooperation substantially adds to the high completeness
and quality of the registry [16]. Diagnoses are coded
according to the International Classification of Diseases
for Oncology ICD-O-3 and classified by the International
Classification of Childhood Cancer ICCC-3 [17].
The methods for the retrospective identification of cases
of Turkish descent in the registry have been described else-
where in detail [7]. In short, the routinely collected regis-
try data does not allow systematically determining
patients' ethnic or geographical origins. We therefore used
a validated name-based algorithm [18,19] to identify
Turkish cases by name. The respective study base were all
registered cancer cases during the period 1980–2005 for
whom the full name was available (n = 37,259, 95% of all
registered cases). The automated name – algorithm proce-
dure was augmented by a manual search done by a
research assistant with proficiency in Turkish language
and names to check the validity of the automated proce-
dure [20]. This procedure has been shown to identify
cases of Turkish descent as indicated by their name
(referred to as Turkish cases) with a high sensitivity
(>97.5%) and specificity (>99%) compared to a complete
manually checked gold standard. In order to maintain the
high degree of confidentiality required, all data base work
was performed at the premises and under surveillance of
the GCCR.
No information was available regarding migrant genera-
tion, but it is likely that especially the more recently diag-
nosed cases contain a large proportion of descendants of
migrants from Turkey who came to Germany in the
1960s.
We assessed the average duration and completeness of fol-
low-up and specifically the percentage lost to follow-up
from the routinely collected data for children of Turkish
and non-Turkish descent.
We calculated total and diagnosis-specific 5-year survival
probabilities for different strata of age, sex and period of
diagnosis (1980–87, 1988–95, 1996–2005) for Turkish
and non-Turkish (largely German) childhood cancerBMC Cancer 2008, 8:355 http://www.biomedcentral.com/1471-2407/8/355
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patients, using the Kaplan-Meier method. The endpoint
was death from any cause. Follow-up ended at the end of
2006 or at loss to follow-up. The statistical significance of
differences in survival probability was assessed by the log-
rank test for the total survival curve. Analyses were
restricted to diagnoses with at least five deaths among reg-
istered cases of Turkish descent. We used the SAS statisti-
cal software package (SAS, Cary, N.C.) for the analyses.
Approval was obtained from the Ethics Committee of the
Medical Chamber Westfalen-Lippe.
Results
Among 37,259 cases in the registry for whom names were
available, we identified 1774 cases (4.76%) with Turkish
descent as indicated by their name. Characteristics such as
sex and age distribution were similar among the two com-
parison groups, but loss to follow-up was somewhat
higher among the cases of Turkish descent (Table 1).
Slight differences in the age distribution reflect the differ-
ent age distributions of the diagnoses, where Turkish cases
are slightly more frequent in some diagnosis subgroups.
Amongst those diagnosed until 2000 and not reported
dead at the end of 2006, the percentage of cases with Turk-
ish descent whose follow-up exceeded 5 years was slightly
smaller (95.8%) than among the non-Turkish registry
population (98.5%). Overall, loss to follow-up of these
cases before the end of 2006 was higher among children
with Turkish ethnicity (12.6% against 5.6% in the com-
parison population). This is mostly due to former patients
moving back to Turkey at a later age. The fraction of Turk-
ish cases was close to the average 4.8% for most diag-
noses. Notable exceptions were acute myeloid
leukaemias, chronic myeloproliferative diseases, myelod-
ysplastic syndrome and other myeloproliferative disease,
lymphomas and reticuloendothelial neoplasms, and
malignant gonadal germ cell tumours with slightly higher
proportions of Turkish cases. We found rather lower pro-
portions of Turkish cases for specified intracranial and
Table 1: Baseline characteristics and quality of follow up in the two groups 1980–2005
Turkish descent
N (%)
Not Turkish
N (%)
Number of cases 1774 35,485
male sex 1042 (58.7) 19,822 (55.9)
Age at diagnosis
<1 year 167 (9.4) 3555 (10.0)
1–<5 years 682 (38.4) 12,914 (36.4)
5–<10 years 503 (28.4) 9516 (26.8)
10–<15 years 422 (23.8) 9500 (26.8)
Year of diagnosis
1980–87 369 (20.8) 7576 (21.4)
1988–95 477 (26.9) 11,366 (32.0)
1996–2005 928 (52.3) 16,543 (46.6)
Median length of follow-up of patients still alive (range) in years 7.1 (0–28) 8.4 (0–28)
Deaths by 31.12.2006 456 (25.7) 8737 (24.6)
Follow-up by period of diagnosis
1980–1995
Alive, at least 10 years f/u 507 (92.0) 12,613 (96.7)
Alive, lost to f/u 93 (16.9) 910 (7.0)
1980–2000
Alive, at least 5 years f/u 879 (95.8) 19,549 (98.5)
Alive, lost to f/u 116 (12.6) 1104 (5.6)
1996–2000
Alive, at least 5 years f/u 357 (97.3) 6725 (98.8)
Alive, lost to f/u 23 (6.3) 194 (2.9)
N = number, f/u = follow-upBMC Cancer 2008, 8:355 http://www.biomedcentral.com/1471-2407/8/355
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intraspinal neoplasms, retinoblastoma, renal tumours,
other specified soft tissue sarcomas, germ cell tumours,
trophoblastic tumours and neoplasms of gonads and
other malignant epithelial neoplasms and malignant
melanomas. The range of proportions is 3.4% to 9.0%
(see Additional file 1). For a more detailed discussion of
these differences see [7].
Overall, 25.7% of the cases of Turkish descent (n = 456)
had died until 2006 compared to 24.6% of cases (n =
8737) with non-Turkish background.
For cases diagnosed between 1980 and 2005, the 5-year
survival probability was 76.9% for cases of Turkish
descent and 77.6% for the comparison group (log-rank
test: p = 0.15). We found no sex or age-specific differences
between the two groups in the overall survival probabili-
ties over the full time period 1980–2005 (Table 2).
Stratification by diagnosis group (see Additional file 2)
showed generally very similar diagnosis-specific survival
probabilities for children of Turkish and non-Turkish
descent. We found a statistically significant disadvantage
for children with Turkish descent only for the group of
leukaemias, myeloproliferative and myelodysplastic dis-
eases (76.2% versus 78.4%; p logrank = 0.028), caused by
the difference in the largest subgroup of lymphoid leukae-
mias (p logrank = 0.013).
Further stratification by time of diagnosis (see Additional
file 3) revealed a significant overall survival disadvantage
of children with Turkish migrant background (64.8% ver-
sus 67.8%, p = 0.016) for the period 1980–87, again
driven by lymphoid leukaemia. The 5-year survival prob-
ability from lymphoid leukaemia diagnosed in the period
1980–87 for non-Turkish children was markedly higher
(75.8%) as compared to the Turkish group (62.0%, p <
0.0001) with a rapid dissociation of the respective survival
curves (see Figure 1). Further analyses (not shown)
revealed no differences in morphological subgroups, age
at diagnosis and completeness of follow-up for this partic-
ular group sufficiently large to explain this difference. Leu-
kaemia cases of Turkish descent both with and without
recorded recurrences had similar survival probabilities,
but Turkish cases had more frequent recurrences. In the
more recent periods, these differences have disappeared
(see Figure 1). The 5-year survival probabilities for leukae-
mia for cases diagnosed 1996–2005 are remarkably simi-
lar between groups and now exceed 80% in both non-
Turkish children and those of Turkish descent.
Based on small numbers, we found survival probability
differences for some diagnosis subgroups and time peri-
ods of central nervous system tumours (e.g. astrocytomas:
1980–87 Turkish (3 events) 80%, Non-Turkish (109
events) 70%, p = 0.89; 1996–2005 Turkish (24 events)
70%, Non-Turkish (334 events) 78%, p = 0.067). Some
further diagnoses show marked survival disadvantages
(e.g other soft tissue sarcomas: 59% (9 events) vs 71%
(173 events, p = 0.11) but also advantages (e.g. Rhab-
domyosarcoma 78% (13 events) vs 69% (422 events, p =
0.50) in general or in some time periods for children with
Turkish descent, but these are all non-significant due to
the rarity of tumours and events.
Discussion
Our data include information from more than 37,000
childhood cancer cases in Germany and show that Turkish
and non-Turkish children in Germany nowadays do not
differ with respect to survival from childhood cancer. This
can be seen as a reflection of the high standard of care
granted to children with cancer in Germany, a standard
which allows equitable and accessible care to all patient
groups irrespective of geographical descent as assessed in
our study. The findings of highly comparable cancer sur-
vival probabilities are largely consistent across diagnostic,
sex and age groups. Only during the early period of the
GCCR, from 1980–1987, when registration was not yet
quite complete, we did see significant survival disadvan-
tages for Turkish children, largely confined to lymphoid
Table 2: 5-year survival probabilities for cancers of children with and without Turkish descent, German Childhood Cancer Registry 
1980–2005 by sex and age at diagnosis.
5 year survival probability % (number of deaths within 5 years of diagnosis)
Turkish descent Non-Turkish p-value, log-rank test
All Malignancies 76.9 (400) 77.6 (7823) 0.15
Boys 77.1 (233) 77.0 (4483) 0.45
Girls 76.6 (167) 78.3 (3340) 0.19
Age at diagnosis
0–<1 years 77.5 (37) 77.1 (806) 0.90
1–<5 years 79.4 (138) 79.2 (2642) 0.69
5–<10 years 76.7 (114) 77.8 (2077) 0.21
10–<15 years 72.9 (111) 75.3 (2298) 0.18BMC Cancer 2008, 8:355 http://www.biomedcentral.com/1471-2407/8/355
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leukaemia. The available data offer little clues why this
difference occurred. So far we have no indication that
incomplete reporting in the early 1980s was related to
prognosis or migrant status, but a selection bias cannot be
entirely excluded. Given the large number of statistical
comparisons we performed, chance may be among the
possible explanations. Problems that could be associated
with e.g. a language barrier, such as parental compliance
with therapy recommendations, appear unlikely, but may
have played a role in certain specific diagnoses with ther-
apeutic regimen that require long-term care after the ini-
tial therapy. There are, however, no recorded data to
further assess this hypothesis. Socioeconomic status did
not change very much for Turkish migrant groups over the
time period investigated, neither did access to medical
care, especially for children. Most of these potential
explanatory factors would also have affected all diagnoses
to the same degree. More important are the recent results
showing very similar survival probabilities in the groups
compared. The actual survival estimates for the most
recent period may be overestimated for all cases due to
incomplete follow-up.
Colour version: Kaplan-Meier estimate of survival curve of lymphoid leukaemia (ICCC3 Ia), cases with and without Turkish  descent diagnosed 1980–87 and 1996–2005 followed up until 12/2006 Figure 1
Colour version: Kaplan-Meier estimate of survival curve of lymphoid leukaemia (ICCC3 Ia), cases with and 
without Turkish descent diagnosed 1980–87 and 1996–2005 followed up until 12/2006. Black line: non-Turkish 
cases diagnosed 1996–2005 (507 events/4559 cases). Blue line: Turkish cases diagnosed 1996–2005 (32 events/265 cases). 
Grey line: non-Turkish cases diagnosed 1980–87 (719 events/2361 cases). Light blue line: Turkish cases diagnosed 1980–87 (52 
events/105 cases).
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Our study ranks amongst the largest investigations of
migrant-specific cancer survival probability. It is based on
the highly comprehensive nationwide German Child-
hood Cancer Registry. The mortality follow-up followed
routinely established procedures and showed very similar
results for both groups, with a surprisingly low loss to fol-
low-up due to out-migration. Our approach to identify
cases with Turkish ethnicity relies on the assumption that
children with Turkish names indeed have a Turkish
descent, and that there is no differential uptake of German
names with regard to cancer prognosis. We cannot
exclude a small bias through this mechanism. However,
the number of mixed German-Turkish marriages has only
increased in more recent years. A major proportion of
these marriages occurs between partners of whom one has
taken up German nationality, but is of Turkish descent.
Thus, Turkish first or family names are likely to be
retained in many mixed marriages. Children from mixed
marriages with neither a Turkish first or last name are
likely to be rare.
In our study we could not differentiate between different
migrant generations. Potentially, such information could
further elucidate the differences in survival probability
seen in early phases of the GCCR, but such data are not
likely to become available in registry – based studies. This
latter comment is also true for information on the socioe-
conomic status of cases or their families, which is not rou-
tinely recorded in the registry.
While the overall number of deaths allows for relatively
precise estimates, the stratifications by diagnosis and
period we performed led to rather small numbers of cases
in some strata. In addition, multiple comparisons should
be noted, but since our study had an explorative character,
no adjustment for multiple testing seemed warranted.
Thus, some of the differences noted as statistically signifi-
cant are possibly due to chance.
Due to the absence of routine data to assess cancer inci-
dence and survival probability according to ethnic back-
ground, this is the first study in Germany on this topic,
and one of the few investigations published in Europe so
far. McKinney [8] assessed the cancer survival probability
in a cohort of 1979 children with cancer in Yorkshire,
using a name-based approach to identify children of
South Asian origin. No survival probability differences
were found between South Asian and other children, and
indications that higher levels of deprivation were linked
with lower survival probability were not statistically sig-
nificant. In a large study of all childhood cancer cases
between 1981 and 1996 in the UK, Stiller [9] found little
evidence of ethnic differences in survival probabilities.
The UK Children's Cancer Study Group register contains
primary information on the ethnic group of patients,
which allows comparisons across different ethnic groups.
For acute lymphoid leukaemia, the authors reported
slightly lower long-term survival probabilities for children
of South Asian origin. Our own finding of survival proba-
bility differences in lymphoid leukaemia mirrors this
observation in one of the largest migrant groups in Ger-
many.
Several studies from the US report ethnic differences in
cancer survival probability, most of them with a focus on
leukaemia. In a series of cases from the St. Jude Children's
Research Hospital spanning 30 years of incident diag-
noses, Pui [10] found large survival disadvantages for
black children in the early periods which disappeared in
the 1980s and 1990s. A single centre study of 412 children
with acute lymphoid leukaemia treated in Memphis also
showed no differences in survival probability [11]. Con-
versely, Bhatia concluded from a review of available sin-
gle-and multi centre studies that black children with acute
lymphoid leukaemia continue to have lower survival
probabilities than white children in the US [12]. For acute
myeloid leukaemias a survival disadvantage of black chil-
dren has recently been described based on experiences
from two US Children's Oncology Group trials [13]. Inter-
estingly, there was only a low proportion of black children
with appropriate matched family donors for transplants.
Overall, the small body of studies available is relatively
consistent with regard to cancer survival probability,
showing generally few differences between cases with and
without migrant background or by ethnic origin. Haema-
tological cancers could be an exception, as, amongst oth-
ers, the recent results from the US indicate. In our own
study, differences in survival probabilities from lymphoid
leukaemia were limited to children diagnosed between
1980 and 1987. Nevertheless, as leukaemias are the larg-
est group of childhood cancers, continued surveillance of
survival using updated markers of ethnic or geographical
origin may be warranted.
Conclusion
In summary, our study demonstrates increasing and very
similar 5-year cancer survival probabilities among chil-
dren with and without Turkish descent living in Germany.
This finding is consistent with the small body of available
information on overall cancer survival of ethnic minority
children from other countries. We interpret this as show-
ing the non-discriminative nature of current childhood
cancer care in Germany and the provision of equitable
access to modern therapeutic and follow-up regimes, irre-
spective of migrant status.
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